Filed provisional patent application, further expanding IP portfolio ...
Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuationsEnrollment to ...
SEC Filings provided by EDGAR Online, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback